Impact and effect mechanisms of mass campaigns in resource-constrained health systems : quasi-experimental evidence from polio eradication in Nigeria by Haenssgen, Marco Johannes et al.
 1Haenssgen MJ, et al. BMJ Global Health 2021;6:e004248. doi:10.1136/bmjgh-2020-004248
Impact and effect mechanisms of mass 
campaigns in resource- constrained 
health systems: quasi- experimental 
evidence from polio eradication 
in Nigeria
Marco J Haenssgen   ,1,2 Svea Closser,3 Olakunle Alonge   3
Original research
To cite: Haenssgen MJ, 
Closser S, Alonge O. Impact 
and effect mechanisms of 
mass campaigns in resource- 
constrained health systems: 
quasi- experimental evidence 
from polio eradication in 
Nigeria. BMJ Global Health 
2021;6:e004248. doi:10.1136/
bmjgh-2020-004248
Handling editor Valery Ridde
 ► Additional material is 
published online only. To view, 
please visit the journal online 
(http:// dx. doi. org/ 10. 1136/ 
bmjgh- 2020- 004248).
Received 19 October 2020
Revised 12 January 2021
Accepted 10 February 2021
1Department of Global 
Sustainable Development, 
School of Cross- Faculty Studies, 
University of Warwick, Coventry, 
UK
2Institute of Advanced Study, 
Milburn House, University of 
Warwick, Coventry, UK
3Bloomberg School of Public 
Health, Johns Hopkins 
University, Baltimore, Maryland, 
USA
Correspondence to
Dr Olakunle Alonge;  
 oalonge1@ jhu. edu
© Author(s) (or their 
employer(s)) 2021. Re- use 
permitted under CC BY. 
Published by BMJ.
ABSTRACT
Background Mass campaigns are a key strategy for 
delivering life- saving interventions under Global Health 
Initiatives, especially in weak health system contexts. They 
are frequently designed parallel to the health system to 
rapidly achieve programme targets such as vaccination 
coverage, but we lack quantitative evidence demonstrating 
their impact and effect mechanisms on health system 
performance at sub-/national level. This longitudinal 
study responds to this gap through an analysis of polio 
eradication campaigns in Nigeria.
Methods Using four rounds of Demographic and Health 
Surveys in Nigeria between October 2000 and December 
2017, we created a longitudinal dataset containing 
88 881 under-5 children/pregnancies. We estimated the 
relationships between individuals’ campaign exposure 
and health system performance indices (full RI schedule 
attainment, maternal healthcare services utilisation and 
child survival) using multilevel, mixed- effects regression 
models applied nationally and stratified by the six 
geopolitical zones in Nigeria.
Results Nationally, high- frequency mass campaigns 
had detrimental health systems effects that potentially 
left 3.6 million children deprived of full immunisation. 
The frequency of campaigns was most concentrated in 
regions with weak health systems, where the operations 
of RI were disrupted, alongside negative effects on child 
survival and institutional delivery. In contrast, regions 
with relatively strong health systems and few campaigns 
experienced beneficial effects on maternal healthcare 
service utilisation.
Conclusions As we provide evidence that well- functioning 
health systems can benefit from mass campaigns under 
Global Health Initiatives, our work also challenges the 
established wisdom to intensify mass campaigns in 
weaker health systems to bypass service provision 
bottlenecks. Mass campaigns do not inherently benefit or 
damage a health system, but frequent campaigns in weak 
health system contexts can impede service provision. We 
call for an additional burden of proof and active efforts to 
integrate mass campaigns into routine health services by 
harmonising implementation plans and service delivery in 
weak health system contexts.
INTRODUCTION
Mass campaigns deliver essential health inter-
ventions to billions of people across the world 
each year. Cost- effective and proven to achieve 
coverage goals, campaigns have become a 
mainstay of global health initiatives (GHIs) 
aiming to reduce population incidence of 
specific diseases.1 2 Using the case of polio 
eradication in Nigeria, we analyse supplemen-
tary immunisation activities (SIAs), a key type 
of mass campaigns in global health, to under-
stand whether and how they may support or 
damage country health system functions.
The Global Polio Eradication Initiative 
(GPEI) is a global multibillion dollar effort 
to eradicate polio, originating from a World 
Health Assembly declaration in 1988.3 Esti-
mates suggest that 125 countries were polio- 
endemic at that time, with an estimated 
350 000 cases per year worldwide.4 While the 
original eradication target of the year 2000 
was not met, significant progress has been 
made, with now only two countries (Afghan-
istan and Pakistan) in which the wild polio-
virus is endemic. Nigeria was the most recent 
country to be declared polio- free—registering 
the last wild poliovirus case in September 
2016—but its path to eliminating polio 
continues to be challenging, as outbreaks of 
circulating vaccine- derived poliovirus type 2 
have continued into 2020.5
A central strategy of the GPEI is the delivery 
of polio vaccine both through routine immu-
nisation (RI) and through mass vaccina-
tion campaigns (SIAs). Official GPEI policy 
has, since the inception of the programme, 
advocated for RI strengthening alongside 
SIAs. However, the GPEI globally and within 
Nigeria de facto prioritised SIAs from the mid- 
1990s until relatively recently.6 7 Much debate 
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has therefore surrounded the question of whether the 
resource requirements and institutional arrangements 
of polio SIAs support8–11 or undermine10 12 13 broader 
health system operations including RI. Despite indicative 
evidence that weak health systems and conflict can mili-
tate against the system strengthening effects of campaign 
inputs,14–16 quantitative studies have not been able to 
establish conclusively a general direction of the impacts 
of campaigns, or the conditions on which those impacts 
depend (see Study Design section for further discus-
sion).10 17–19
Nigeria is an excellent case study for examining this 
question because, as one of the world’s last polioendemic 
countries, it has until recently continued frequent SIAs. 
In Nigeria, SIAs are multiday events where oral polio 
vaccine (OPV) is delivered both at fixed sites and door 
to door, with the aim of achieving high coverage among 
children under the age of 5. Some of these campaigns 
are nationwide, but areas with polio transmission are 
targeted with many additional sub- national campaigns.
Based on a nationwide, repeated cross- sectional and 
multilevel assessment of individual exposure to SIAs 
since birth and during pregnancy, we provide systematic 
evidence that resource- intensive and labour- intensive 
SIAs in Nigeria are concentrated in areas with relatively 
weaker health systems, and increased frequency of SIAs 
can have significantly disruptive effects in these areas. 
Conversely, SIAs are conducted with less frequency in 
areas with relatively stronger health systems, and asso-
ciated with beneficial outcomes in these areas. Hence, 




Our study design responds to the methodological 
challenges in assessing the heterogeneous impacts of 
mass campaigns on country health systems; these chal-
lenges have resulted in mixed and inconclusive results 
in previous quantitative research on the topic. Much of 
this work consists of descriptive studies. Aylward et al20 
interpreted the association between SIA and vaccine 
coverage trends as evidence of synergies between polio 
eradication and RI performance. A more recent descrip-
tive study, a cross- sectional survey of GPEI- related staff 
in 10 countries by van den Ent et al,14 found that polio 
staff spent time strengthening RI- related activities but 
also mentioned that this was easier to do in settings 
with fewer campaigns. Other descriptive research has 
involved observational studies of routine service delivery 
in primary care settings during SIAs. Mounier- Jack et al15 
in Cameroon documented disruption of antenatal care 
and vaccination services as a result of frequent health 
campaigns including SIAs, and Omoleke et al16 indicated 
a lack of integration between RI, that is, facility- based 
Expanded Programme Immunisation (EPI) activities, 
and SIAs in Nigeria that could potentially be detrimental 
to immunisation services delivery. Although insightful, 
conclusions about impacts often remain speculative in 
this descriptive work.
Quasi- experimental analyses have produced simi-
larly mixed results. Using individual- level data from the 
Demographic and Health Surveys (DHSs), Bonu et al17 
studied RI uptake before and after the introduction of 
polio eradication efforts between 1990 and 2001 in 15 
countries, finding heterogeneous developments of RI 
coverage over time and even declines of routine polio 
vaccination in some countries including Nigeria despite 
the introduction of SIAs. Focusing specifically on routine 
OPV, Helleringer et al21 concluded from an analysis of 
DHS data covering 20 countries that self- reported SIA 
Key questions
What is already known?
 ► Mass campaigns are a key strategy to deliver interventions under 
Global Health Initiatives, for example, supplementary immunisation 
activities (SIAs) and are often most heavily used in weaker health 
systems to bypass service provision bottlenecks.
 ► The health system effects of mass campaigns are disputed: 
Commonly cited positive impacts include the strengthening of sur-
veillance, management, and logistical systems and health service 
demand generation, but resource and workforce requirements of 
mass campaigns can also drain capacity to provide routine ser-
vices, and frequent campaigns may lead to public resistance.
 ► Studies indicate that context matters for mass campaigns: the im-
pact of large numbers of SIAs is likely to be more disruptive in weak 
health systems, but conclusive quantitative evidence is lacking.
What are the new findings?
 ► Regions of Nigeria with relatively strong health systems had less 
frequent campaigns and also experienced beneficial effects of 
campaigns on maternal healthcare service utilisation. In contrast, 
regions with weak health systems had more frequent mass cam-
paigns, which were more likely to disrupt routine immunisation and 
to compromise child survival and institutional delivery.
 ► On the national level, the health system effects of more frequent 
mass campaigns potentially left 3.6 million Nigerian children be-
tween 2000 and 2017 unvaccinated for the full immunisation 
schedule.
 ► Our methodologically innovative study clarifies how both positive 
and negative impacts of mass campaign programmes (such as 
SIAs) on health systems may be derived within the same country 
setting—thus confirming patterns that have been laid out in the 
qualitative literature.
What do the new findings imply?
 ► While SIAs can complement strong health systems and may be the 
only viable option for providing services in fragile and emergen-
cy settings, the conventional logic of targeting mass campaigns to 
overcome health system weaknesses can also be detrimental for 
weak health systems.
 ► Given the significant risk of disrupting weak health systems, mass 
campaigns should be purposively designed and implemented in 
ways that facilitate routine health services provision.
 ► Global health initiatives should work with local stakeholders to 
strengthen health systems, share resources and harmonise imple-
mentation plans for mass campaigns and service delivery.
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participation was linked to higher vaccine uptake among 
poorer economic strata of the population. In contrast, 
Closser et al10 found that ‘to the degree that polio eradi-
cation campaigns have an effect on outcomes in RI and 
maternal healthcare, (the modestly positive yet overall 
mixed) effects are small relative to other factors and 
are inconsistent from place to place’—based on cross- 
national panel data (regressing national- level health 
system indicators against SIA onset and average number 
of SIAs per year) and individual DHS data from seven 
countries (relating individual- level and district- level 
outcomes to the aggregate incidence of SIAs).
A main challenge in these studies is the direct attribu-
tion of changes in health system performance to the oper-
ation of SIAs. More recent research has therefore made 
use of unique variation in children’s direct exposure to 
SIAs. For instance, a study by Helleringer et al22 in Bangla-
desh analysed the random timing of births before and 
after a national mass immunisation campaign. Limiting 
their focus on children aged 4 months, the authors 
argue that one- time exposure to the SIA (comparing 
children born before and after the campaign) signifi-
cantly increased uptake of the diphtheria, pertussis and 
tetanus vaccine (DPT) vaccine as well as routine child-
hood immunisation more broadly. A related study by 
Chakrabarti et al18 expanded the analysis to the broader 
target group of children under 5 years of age. Using the 
time when a child was first exposed to one SIA as an 
instrumental variable for total SIA exposure, the authors 
found an overall negative relationship between SIA and 
RI, which was statistically significant in three out of five 
countries for the period 1992–2013. Haenssgen19 further 
incorporated subnationally varying SIAs (ie, subnational 
polio immunisation days and mop- up campaigns) into 
quasi- experimental exposure assessments, based on geo- 
coded child- level data from the District Level Household 
and Facility Survey in northern India between 2002 and 
2008. This study detected an overall negative associa-
tion between SIA exposure and RI attainment in Uttar 
Pradesh, whereby age- specific results suggested that older 
children may be deprived of the opportunity to catch 
up on missed routine childhood vaccines. However, the 
analysis also demonstrated a positive association between 
SIAs and RI in neighbouring Bihar, which had simi-
larly intense SIAs but placed comparatively more policy 
emphasis on synergies between polio eradication and RI.
Overall, quantitative assessments of SIA impacts on 
country health systems have undergone substantial evolu-
tion, involving a move towards precise quasi- experimental 
methods, fine- grained analyses of SIA exposure on the 
individual level, and an expansion of health service assess-
ments beyond RI. We built on the quasi- experimental 
design by Haenssgen19 to assess the health system impact 
of SIAs at the individual (child) level. Given that the 
nationwide implementation of the Polio Eradication 
Initiative limits the study of like- for- like counterfactual 
settings, we studied different degrees of exposure to 
various numbers of recurring SIAs on individual (child/
pregnancy) outcomes. Our study design exploited exoge-
nous variation in children’s birth dates and survey imple-
mentation at an unprecedented level of precision (based 
on exact implementation dates of SIAs and birth dates 
of children), while controlling for individual, maternal, 
household and locational determinants of health service 
utilisation in a multilevel regression design that helps 
to take within- country variation of health system perfor-
mance into account.
Country setting
Nigeria has a population of around 200 million people—
and over 40% of this population is under the age of 
18.23 Hence, maternal and child health issues including 
immunisation play an outsized role in shaping the health 
system. The country is comprised of 36 states and 774 
local government areas (LGAs). The health system is 
decentralised along three tiers: federal, state and LGA 
levels. The states are often grouped into six geopolitical 
regions: North- Central, North- East, North- West, South- 
East, South- West and South- South. Significant variations 
exist in health system performance across these regions, 
with generally better indicators of service delivery in the 
southern regions.24
Patient and public involvement
It was not appropriate or possible to involve patients or 
the public in the design, or conduct, or reporting, or 
dissemination plans of our research.
Data
This analysis used four rounds of geo- coded DHSs 
(DHSs; https:// dhsprogram. com/) from Nigeria, from 
2003, 2008, 2013 and 2018. DHSs are standardised and 
nationally representative surveys of health and educa-
tion measures. We harmonised the datasets across the 
survey rounds to ensure consistent measurement of key 
indicators such as household wealth or ethnic group. We 
subsequently matched the DHS data with a calendar of 
national and subnational SIAs in Nigeria from October 
2000 until December 2017. Geospatial analysis using 
ArcGIS V.10.5.1 with administrative boundary data from 
United Nations Office for the Coordination of Humani-
tarian Affairs Nigeria25 enabled us to identify the LGAs in 
which the 3533 DHS clusters were located.
Because SIAs aim at full coverage of all children in a 
target area, we assumed that all children in a targeted 
LGA would have been exposed to the SIA. There were 
312 campaigns recorded in the calendar from October 
2000 until December 2017, and 145 of these were SIAs 
mobilised for polio eradication using OPV and included 
25 national immunisation days (which also include, 
eg, vitamin A administration), 16 subnational immu-
nisation days, 17 immunisation- plus days (which also 
provide, eg, oral rehydration solutions, anthelmintics 
and paracetamol), 57 subnational immunisation- plus 
days, 27 mop- up campaigns or ‘outbreak response’ activ-
ities and three maternal/neonatal/child health weeks 
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(a visual summary of these SIAs is presented in online 
supplemental figure 1.26 Over the period from October 
2000 to December 2017, the total number of registered 
SIAs ranged from 45 to 120 per LGA—which yielded a 
total of 59 127 LGA- SIA pairs (covering the 774 LGAs in 
Nigeria). The overall accuracy of matching SIAs to LGAs 
was 96.55%.
From the combined data set, we excluded women who 
were not usual residents of the households in which 
they were interviewed, all children born before the first 
recorded SIA (October 2000), all survey interviews after 
the last SIA in our register (December 2017), observa-
tions that could not be matched to an LGA, and house-
holds who had migrated to the survey sites after the child 
was born. The remaining sample contained 88 881 obser-
vations, spanning 690 LGAs and including 8681 pregnan-
cies with a child that did not live to its fifth birthday. Using 
the information on SIA dates, we were able to calculate 
the number of campaign rounds to which children and 
pregnancies were exposed. We defined three relevant 
periods: pregnancy period; RI period, that is, birth until 
age 10 months (when children are expected to receive 
facility- provided EPI schedule of childhood vaccines, 
including DPT) and follow- up period, that is, after age 
10 months (when children are expected to catch- up on 
missed vaccines according to the schedule).
Analysis
To assess the impact of SIAs on RI and other health 
system functions, we estimated multilevel logistic and 
linear regression models. In broad terms, these models 
predict healthcare utilisation/outcomes with SIA expo-
sure (‘EXP’) as key independent variable alongside a 
range of standard control variables such as socioeco-
nomic status that are commonly identified in the child-
hood immunisation literature (see online supplemental 
table 1 for variable summaries and online supplemental 
table 2 for an overview of the models reported here).27–29
The three outcomes in our models were full child-
hood immunisation, maternal healthcare utilisation and 
child survival. Access to full immunisation was assessed 
using a binary index (‘1’ if a child had attained three 
doses of DPT vaccine, one dose of Bacillus Calmette- 
Guerin (BCG) vaccine, and one dose of measles vaccine). 
Contrary to the Nigerian RI schedule,30 the DHSs did not 
cover hepatitis B vaccination. We excluded OPV from the 
indicator for assessing full immunisation owing to poten-
tial endogeneity (given that our main exposure variable, 
SIAs, involves the administration of OPV via campaigns) 
and recall biases (given that high exposure to SIAs and 
social mobilisation activities that often accompany SIAs 
may positively influence a parent’s recall of his or her 
child’s OPV uptake as part of the full immunisation 
schedule).31 32 Because older children may be differen-
tially affected by SIAs (eg, missed follow- up vaccines), we 
also disaggregated the relative contribution of exposure 
during the RI and follow- up periods and analysed inter-
actions between exposure and child age (‘EXPxAGE’).19 
Maternal healthcare utilisation indicators included the 
number of antenatal care visits and tetanus toxoid injec-
tions before birth as well as the place where the child 
was delivered (at home, private facility, public facility). 
Lastly, we studied child survival as a function of SIA expo-
sure during pregnancy and after the birth of the child. 
As exact birth date information was not always available 
for children who did not survive (ie, the day of birth is 
missing), we used monthwise birth date approximations 
for the SIA exposure measurement.
These analyses were carried out at the individual 
child/pregnancy level. However, poor health system 
development at the LGA level may be associated with 
poor coverage of health services, including full immu-
nisation for children, and this may necessitate more 
frequent SIAs. Hence, we estimated two- level models 
with an LGA random effect (level 2) to account for varia-
tions in health system development comparing LGAs. To 
support the development of policy recommendations in 
light of health system differences, we also stratified the 
analysis across the six regions in Nigeria; the Northeast 
and Northwest contain the poorest performing health 
systems. Furthermore, because potential disruptions may 
be better managed over time as health systems adapt to 
SIAs, we also analysed two- way and three- way interactions 
between the survey year variable, SIA exposure, and child 
age to detect such dynamic effects.
As part of our robustness checks, we carried out three- 
level analyses with an additional state random effect 
(level 3), noting, however, that states face considerable 
within- state variation in SIA frequency and intensity, 
owing to which we limit the reporting of our main results 
to the two- level model specifications (level 2: LGA, level 
1: individual child/pregnancy). Other robustness checks 
included: excluding the DHS 2018 survey round (because 
most of the SIAs during that year were mop- up activities), 
stratifying the dataset by DHS- round as an alternative 
approach for assessing time trends, regressing on a full 
immunisation outcome that excludes measles, analysing 
decomposed SIA exposure (with exposure for national 
immunisation days, immunisation plus days, mop- up 
campaigns and maternal/neonatal/child health weeks 
as separate variables), and estimating the main models 
with LGA- level fixed effects. These robustness checks are 
reported in (online supplemental tables 3b–5b for the 
3- level models, (online supplemental table 6a) for the 
analysis excluding DHS 2018, (online supplemental table 
6b) for the time trends analysis, (online supplemental 
table 6) for the full immunisation outcome excluding 
measles, (online supplemental table 6) for the analysis 
with decomposed SIA exposure and online online supple-
mental table 6 for the fixed LGA effects models). Overall, 
the results based on these robustness checks were consis-
tent with our main results. Although the Hausman tests 
suggested that the fixed effects models may be preferable 
for the maternal healthcare services utilisation and child 
survival outcomes, the inclusion of 774 LGA dummy 
variables in the stratified analyses impacted model fit 
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(complete separation), and the model failed to converge. 
Moreover, the Hausman tests may be sensitive to large 
samples as was the case in our analyses.33 34 Hence, we 
report random effects results for consistency. All statis-




Table 1 depicts the main results on the link between SIA 
exposure and non- polio full immunisation (see online 
supplemental table 3 for the detailed results). The results 
indicate a negative and statistically significant association 
between SIA exposure since birth and children’s attain-
ment of non- polio full immunisation. Model 2 shows 
that the coefficients for SIA exposure during the RI and 
follow- up periods had the same direction and point esti-
mates, but only the latter was statistically significant at the 
1% level. The interaction model (model 3) suggests that 
the association between SIA exposure and full vaccina-
tion also becomes increasingly negative with child age. 
Two- way and three- way interaction terms involving the 
survey round dummy were not statistically significant 
(see online supplemental table 3), indicating that the 
relationship between SIA exposure and RI attainment 
did not change across the period 2000–2017.
Based on these results, the full model predicts that 
children not exposed to SIAs had an average probability 
of non- polio full immunisation of 22.4% (95% CI 20.0% 
to 24.7%), whereas children with 10, 20 and 40 rounds 
of exposure had a probability of 18.6% (95% CI 17.5% 
to 19.7%), 15.4% (95% CI 13.6% to 17.2%) and 10.3% 
(95% CI 6.9% to 13.6%), respectively (figure 1A). The 
age- specific results further suggest that, whereas exposure 
to 10 SIAs is predicted to yield a 0.3% point higher prob-
ability of non- polio full immunisation for a 10- month- old 
child compared with an unexposed child, the same expo-
sure for a 30- month- old child would entail a 2.7% point 
lower predicted probability, and a 7.5% point lower prob-
ability for a child aged 50 months (figure 1B).
Maternal health service utilisation
The results about maternal health service uptake are more 
mixed. Table 2 presents the main findings for SIA exposure 
during pregnancy separated by place of delivery and ante-
natal care (see online supplemental table 4 for the detailed 
Table 1 Main results: link between SIA exposure and routine childhood immunisation uptake
Dependent variable:
Non- polio full immunisation Full model Exposure decomposition by period Interaction model (EXPxAGE)
Model no (1) (2) (3)
EXP_CHI −0.024† 0.012







CHI_AGE 0.078† 0.078† 0.038†
(0.063 to 0.093) (0.063 to 0.093) (0.031 to 0.044)
CHI_AGE2 −0.001† −0.001†
(−0.001 to –0.001) (−0.001 to –0.001)
Level 1 observations (child) 24 381 24 381 24 381
Level 2 observations (LGA) 684 684 684
Akaike information criterion 18 030.298 18 032.469 18 055.959
Prob.>Χ2 <0.001 <0.001 <0.001
Notes. Two- level logistic regression with LGA random effect. Sample include children aged 10–60 months who were alive at the time of the 
survey and born between Octber 2000 and December 2017. Dependent variable: full immunisation, defined as at least one dose of BCG, 
three doses of DPT and one dose of measles vaccine as recalled by mother and/or reported by child’s health card. Main results only, omitting 
child, parental and household determinants of immunisation, survey round dummy, constant and multilevel variance parameter. Interaction 
terms between SIA exposure and survey round dummy were not statistically significant and the associated models have been omitted from 
the main results. Coefficients reported, 95% CIs in brackets.
*P<0.10.
†P<0.01.
BCG, Bacillus Calmette- Guerin; DPT, diphtheria, pertussis and tetanus; LGA, local government area; SIA, supplementary immunisation 
activity.
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results). Only the coefficient for delivery in private facilities 
was statistically significant (at the 1% level) yet negative. 
Year interactions did not yield statistically significant results 
for any of the maternal health service indicators considered 
here, suggesting again that the overall associations did not 
change over the study period.
Child survival
Table 3 presents the main results for child survival 
suggesting that SIA exposure may be negatively associ-
ated with child survival (see online supplemental table 5 
for the detailed results). The results of model 1 in table 3 
suggest that prebirth SIA exposure (EXP_PREG_nod) 
did not have a statistically significant association with 
child survival, whereas postbirth exposure (EXP_CHI_
nod) was negatively and statistically significantly linked to 
Figure 1 Predicted probability of (non- polio) full immunisation as a function of SIAs to which a child had been exposed since 
birth (A) and as function of child age (B). Source: authors. Notes. prediction based on models 1 and 3 in table 1 for children 
aged 10–60 months (n=24 381), controlling for child, parental and household determinants of immunisation with survey round 
dummy and LGA random effect. Full immunisation defined here as at least one dose of BCG, three doses of DPT and one dose 
of measles vaccine as recalled by mother and/or reported by child’s health card. DPT, diphtheria, pertussis and tetanus; LGA, 
local government area; SIAs, supplementary immunisation activities; BCG, Bacillus Calmetter- Guerin.




At home At private facility
At public 
facility
No of antenatal 
care visits
No of tetanus 
toxoid injections
Model no (1) (2) (3) (4) (5)
EXP_PREG 0.007 −0.065† 0.010 −0.025* 0.001
(−0.013 to 0.027) (−0.093 to –0.036) (−0.009 to 
0.029)
(−0.054 to 0.003) (−0.008 to 0.009)
Level 1 observations (child) 34 713 34 713 34 713 35 019 36 585
Level 2 observations (LGA) 686 686 686 686 687
Akaike information criterion 26 422.845 17 601.384 30 318.818 193 640.288 111 227.001
Prob.>χ2 <0.001 <0.001 <0.001 <0.001 <0.001
Notes. Two- level regressions with LGA random effect (see notes a and b for model specification). Sample include pregnancies for children 
born between October 2000 and December 2017 (the available data for the covariates means that the sample is limited to live births). 
Dependent variables as defined in table header. Main results only, omitting maternal and household determinants of healthcare access, 
survey round dummy, constant and multilevel variance parameters. Interaction terms between SIA exposure and survey round dummy were 
not statistically significant and the associated models have been omitted from the main results. Coefficients reported, 95% CIs in brackets.
*P<0.10.
†P<0.01.
‡Two- level logistic regression models with binary outcome indicators of facility access for delivery.
§Two- level linear regression models of number of antenatal care visits and tetanus toxoid injections prior to delivery. Two- level Poisson 
regression models yielded similar results and have been omitted from reporting.
LGA, local government area; SIA, supplementary Immunisation activity.
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child survival (at the 1% level). The combined exposure 
in model 2 (EXP_TOT_nod) exhibited a similar trend. As 
before, the year interaction with total SIA exposure was 
not statistically significant. For illustration, the predicted 
probability of survival as a function of SIA exposure as 
per model 1 (controlling for all covariates including 
child age, predictions based on postbirth exposure 
only) suggest that a child with zero SIA exposure since 
birth had a 95.2% probability of survival (95% CI 94.8% 
to 95.6%), whereas children exposed to ten SIAs had a 
0.9% point lower probability of 94.3% (95% CI:94.0% to 
94.5%).
Disaggregated results
Considering the argument that weak health systems 
are particularly vulnerable to disruptions from mass 
campaigns, we demonstrate in online supplemental table 
6 that SIAs in Nigeria were concentrated in regions with 
relatively poorer health system performance and lower 
wealth index (Northwest, Northeast). For example, 
compared with the Southwest region, LGAs in the 
Northwest region had more than twice the number of 
SIAs during the study period (114 vs 47), while the full 
immunisation rate of children in the complete survey 
sample was only one- fifth compared with children in 
the Southeast region (8.3% vs 40.6%). As a result of the 
subnational variations in SIA frequency as a result health 
system challenges, we analysed the relationship between 
SIA exposure and health service utilisation stratified by 
the six regions of Nigeria.
The main results of the stratified analysis are presented 
in table 4, which shows the regression coefficients for SIA 
exposure across regions and the various outcome variables 
(see online supplemental table 7 for the detailed results). 
The stratified analysis has a lower statistical power due 
to smaller samples. However, the overall negative and 
significant association between SIA exposure and non- 
polio full immunisation persisted in the two regions 
with the poorest health system performance (Northwest, 
Northeast). The exposure–child age interaction term 
was furthermore statistically significant and negative in 
the Northcentral, Southeast and South- South, suggesting 
that the only region without a detectable relationship 
between a negative full immunisation outcome and SIAs 
was the Southwest. The statistical associations suggest 
that, for instance, children in the Northwest with zero 
SIA exposure had an average predicted probability of 
9.4% of full immunisation, whereas the predicted prob-
abilities for children with 10 and 20 rounds of exposure 
were 4.8% and 2.3%, respectively. The negative inter-
action terms in the better performing South of Nigeria 
suggest that younger children may indeed be more likely 
to receive their scheduled shots if exposed to SIAs, while 
further exposure of older children to additional SIAs may 
not improve their likelihood of catching up on previously 
missed scheduled vaccines.
For maternal healthcare utilisation, a positive and 
statistically significant relationship between antenatal 
care and SIA exposure during the pregnancy emerged in 
regions with relatively better health system performance. 
These associations suggest, for instance, that a mother in 
the Southeast region exposed to five rounds of SIAs was 
predicted to make 8.7 antenatal care visits compared with 
7.9 visits for unexposed mothers. In contrast to health-
care utilisation, the child mortality results did not persist 
Table 3 Main results: link between SIA exposure and child survival
Dependent variable: child survival Exposure decomposition Total exposure
Model no (1) (2)
EXP_PREG_nod (date approximation) −0.012
(−0.034 to 0.010)
EXP_CHI_nod (date approximation) −0.019†
(−0.029 to –0.009)
EXP_TOT_nod (total exposure, date approximation) −0.018†
(−0.027 to –0.009)
Level 1 observations (child) 52 431 52 431
Level 2 observations (LGA) 689 689
Akaike information criterion 23 684.534 23 682.853
Prob. >Χ2 <0.001 <0.001
Notes. Two- level logistic regression with LGA random effect. Sample includes children up to 60 months of age (or aged 60 months at time 
of death) born between October 2000 and December 2017. Dependent variable: child is alive. Main results only, omitting child, parental and 
household determinants of immunisation, survey round dummy, constant and multilevel variance parameter. Using date approximations 
(year- month) as exact birth date information not available for children who did not survive. Total SIA exposure (EXP_TOT_nod) combines 
exposure during pregnancy and after birth and is used for interaction models (interaction terms were not statistically significant and were 
omitted from main results). Coefficients reported, 95% CIs in brackets.
*P<0.10.
†P<0.01.
LGA, local government area; SIA, supplementary immunisation activity.
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in the stratified analysis, suggesting that this association 
may be relatively weak overall (aggregate fixed effects 
regression results presented in online supplemental 
table 6 suggest that an effect may nonetheless be present, 
rather than being a product of reverse causality).
In support of the subregional heterogeneity described 
here, the intraclass correlations of the explanatory vari-
ables included in our random effects models ranged from 
1.2% (child survival) to 21.8% (antenatal care visits) (see 
online supplemental table 8). This suggests that health 
system factors mapped to the LGA level (level 2) explain 
a substantial proportion of the variance in our models.
DISCUSSION
Our analysis showed a negative overall relationship 
between mass campaign exposure and routine health 
services performance, especially for full immunisation 
catch- up among older children, and to a lesser extent 
for delivery and child survival. Campaigns were more 
frequent in areas with weaker health systems—a finding 
reflective of unofficial global GPEI strategy—which 
appears to have driven the overall negative relationship 
between full immunisation and SIAs. SIAs may in fact be 
associated with increased maternal health services utili-
sation in regions with relatively stronger health systems 
(Southeast, Southwest). The type of SIA (eg, national 
immunisation days, immunisation plus days, mop- up 
campaigns and maternal/neonatal/child health weeks) 
was not differentially associated with the outcomes 
(online supplemental table 6), which suggests that the 
shared characteristic as ‘campaigns’ dominates in the 
observed relationship, rather than the specific combina-
tion of activities within the different types of SIA.
While other studies have come to similar conclusions 
about the relationship between mass campaigns and 
health system performance,10 17–19 35 our study is one of 
the first to quantify the magnitude and subnational varia-
tion of their impacts on health systems. Thus, we address 
a major methodological challenge of directly attributing 
changes in health system performance to the operation 
of SIAs using quantitative models. Our study is supported 
by the quality of the underlying DHS data and their 
nationally representative samples from multiple survey 
years.
Our analysis is limited by our inability to evaluate 
systemic changes arising from the introduction of SIAs 
as part of other broader GHIs apart from GPEI. Cross- 
national before- and- after comparisons are better suited to 
assess such impacts, which might well extend beyond the 
indicators assessed here, including, for instance, Ebola 
or helminths control.8 36 In addition, our analysis may 
be susceptible to omitted variable bias (eg, specific LGA 
factors that influence service delivery outcomes)—but 
our wide range of evidence- based explanatory variables, 
the use of random effects models, and our robustness 
checks as reported in online supplemental file 1, at least 
partly offset this risk.
As we focus analytically on the impacts of SIA expo-
sure in the presence of sub- national health system 
variation, this study also does not directly examine the 
underlying drivers that explain people’s relationship to 
government health services or vertical interventions. This 
point, however, has been addressed in related work.37–39 
What for instance materialises as ‘distrust’ towards the 
government and vaccination campaigns in Nigeria’s 
northern regions (also illustrated in box 1 below) is 
arguably rooted in deprivation, discrimination, colonial 
Box 1 Case studies of polio eradication in Nigeria
Polio campaigns and health systems in the Northwest 
region: Kano state, 201210 38
The polio campaign in Kano state in January 2012 was kicked off 
in a pavilion with cushioned chairs for assembled dignitaries. Soap, 
whistles, biscuits and infant clothes were prominently displayed on 
large tables to entice mothers to bring their children in for vaccination.
At the same time, teams of health workers went door to door 
with polio vaccine. Refusals were common in some areas. Workers 
commented that there was a stark contrast between poor- quality 
health services and frequent, well- funded polio campaigns, which 
made people nervous. A community health worker said, ‘People keep 
asking, why is it that polio vaccine is to be taken house to house and 
free of charge, while if you go to the hospital other drugs are never 
free. This makes people raise a question mark even on the other 
routine vaccines given at the hospital free of charge.’38
Health centres in the area had cracked walls and broken 
refrigerators, were frequently out of basic supplies, and were often 
short of staff. These staff shortages were exacerbated during polio 
campaigns. A health worker commented, ‘Once the polio campaign 
is flagged up, every other activity is halt in the primary health 
centre, because every high official’s attention will focus on the polio 
campaigns.’
‘Eighty per cent of the healthcare activity will stop until the polio 
campaign days are over,’ another worker added.10
Polio campaigns and health systems in the Southwest 
region: Ondo state, 201344 45
For the year of 2012, Bill Gates, along with President Goodluck 
Jonathan, announced the ‘Governor’s Immunisation Leadership 
Challenge’—a competition for Nigerian states to increase their 
polio campaign and immunisation coverage. The idea was that by 
providing large monetary prizes of up to US$1 million, states would 
be incentivised to increase immunisation coverage enough to finally 
eliminate polio from the country.
States competed to improve their polio campaign performance 
data, and in 2013, Ondo state was announced the winner. Energised 
by this win, state officials poured the US$500 000 in prize money into 
scaling up its fledgling Healthy Mothers Healthy Babies programme, 
expanding it into more facilities, and creating and aggressively 
tracking new indicators on maternal mortality. The governor said, 
‘Winning the Bill and Melinda Gates Polio Challenge was an added 
impetus to pursue more aggressive healthcare projects in the state.’44
Thus, policy- makers and managers of a state with relatively 
strong health system in the Southwest region used polio assets to 
strengthen broader health system goals. Kano state, the case study in 
the Northwest region described above, also entered the Immunisation 
Leadership Challenge. However, their immunisation coverage was too 
low to receive any prize money.45
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histories and the local epidemiological context. Glob-
ally, culture and religion are also often mentioned as 
key factors shaping people’s relationship to government 
health services, but extensive research has linked these 
patterns to underlying historical trauma that population 
subgroups have experienced—rather than, for example, 
the practice of religion itself—alongside issues of power 
in global health policy- making.37–39 These underlying 
factors determining people’s health service utilisation 
and their relationship to the government are related to 
our findings. Ethnographic work shows that in northern 
Nigeria, vaccine hesitancy is fuelled by heavy government 
focus on frequent, well- funded polio campaigns in the 
context of crumbling health systems—the discrepancy 
makes already distrustful people nervous.38 39
We take our results therefore as evidence that SIAs do 
not inherently benefit or damage a health system, but 
that large numbers of campaigns in weak health system 
contexts may strain limited capacity, and create systemic 
issues leading to adverse outcomes (see box 1).39 In 
contrast, stronger health systems are more able to take 
advantage of added resources that mass campaigns 
provide to produce beneficial outcomes.10 40 Hence, 
the programmatic and health system effects of mass 
campaigns are mainly determined by the critical inter-
action between mass campaigns and health systems in 
context.
In areas with weak health systems and low full immu-
nisation coverage across the world, the GPEI made a 
strategic decision to increase the number of campaigns, 
rather than using funding to support RI. This correlation 
holds in Nigeria as it does globally.10 Thus, the health 
systems most in need of support were targeted with high 
numbers of SIAs that this analysis shows can cause further 
damage to the health system. The scale of such damage 
can be considerable. Based on our results (and given 
average numbers of SIAs and cohort sizes of the under-5 
population), we estimate that, between 2000 and 2017, 
every additional SIA was associated with between 41 700 
and 127 500 Nigerian children deprived from being fully 
immunised. Over our entire study period, this translates 
into lost opportunities to fully immunise more than 
3.6 million children (these effects primarily pertain to 
young children rather than infants given the age- specific 
non- linear relationship between SIA exposure and full 
immunisation). These numbers do not represent an exact 
accounting: the relationship between a heavy campaign 
burden and a very weak health system is complex. But 
our analysis shows that repeated campaigns (on a near- 
monthly basis in some areas) can further interfere with 
already weak health services provision.
Our study shows that these disruptive effects do not 
improve or change over time, suggesting that health 
systems do not evolve passively to mitigate disruptive 
impacts of SIAs. Nigeria and the African region were 
recently certified polio- free (although vaccine- derived 
polio persists),41 and plans are underway to repurpose 
the SIAs for delivery of other health interventions. It is 
important for policy- makers and health system managers 
in Nigeria and elsewhere to actively harmonise implemen-
tation plans and service delivery between mass campaigns 
and routine health services. This can be achieved by 
focusing on support for mid- level district health officers 
and front- line health workers, who are often respon-
sible for both routine services and SIAs. Given the worse 
outcomes for children older than 10 months associated 
with high- intensity SIAs, it is important that any inte-
grated plan includes activities for providing services to 
children above the age of 10 months who missed their 
routine shots, especially in the Northwest and Northeast 
of Nigeria.
We do not call for abandoning mass campaigns as a stra-
tegic approach since they may be the only viable option 
to providing services and saving lives in fragile and emer-
gency settings. Rather, as mass campaigns can leave a weak 
health system worse- off, implementing such programmes 
should require an additional burden of proof that the 
programmes’ design and intensity will at least not disrupt 
and ideally facilitate the operation of routine services. 
Prior system readiness assessments should contextualise 
and adapt mass campaigns to their contexts, nationally 
and subnationally. Such adaptation requires adopting and 
implementing explicit goals to strengthen weak health 
systems as part of the campaign programme (rather than 
divorced from them and delivered by another entity). 
The ensuing health system strengthening strategies 
should be locally owned and could involve, for example, 
production of human resources for health and other 
health services inputs to accompany mass campaigns 
(or in fact be adopted in lieu of repeated campaigns) in 
weaker health systems. While such an approach is likely 
to yield the twin goals of achieving the specific program-
matic outcomes of a campaign (eg, raise immunisation 
coverage for a specific antigen) and support of the health 
system, it is likely to be more cost- intensive and time- 
intensive and will require cooperation and coordination 
of processes among multiple stakeholders.
The health system impacts of mass campaigns are a 
critical subject in light of persistent aspirations in global 
public health to control infectious diseases (eg, malaria 
and measles) through mass campaign programmes, and 
in light of likely future mass immunisation campaigns for 
emerging infectious diseases such as the COVID-19. Our 
study speaks not only to SIAs for polio eradication but to 
the broader use of mass campaigns.42 43 We are not making 
a general argument for or against mass campaigns; the 
health system context (including actors, institutions, 
infrastructure, processes and overall capacity) drives the 
result of these campaigns,35 and there are trade- offs. For 
example, policy- makers may need to weigh the benefits 
of averting a crippling infectious disease for thousands 
of children against the costs of depriving them of other 
vital routine services, and potentially contributing to 
higher mortality—from conditions addressed by those 
routine services—in areas with weak health systems 
where frequent SIAs are targeted. Proponents of SIAs 
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as a major tool should be open and more circumspect 
about their potential for health system disruptions. The 
design and implementation of such campaigns should be 
approached with an understanding of the health system 
context—and should include strategies to strengthen 
routine health services and not work around them.
Twitter Marco J Haenssgen @HaenssgenJ
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